OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 86 citing articles:

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 83

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 63

Patient-derived organoids in translational oncology and drug screening
Ruixin Yang, Yingyan Yu
Cancer Letters (2023) Vol. 562, pp. 216180-216180
Open Access | Times Cited: 54

Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 19

Construction of tumor organoids and their application to cancer research and therapy
Jiajing Lv, Xuan Du, Miaomiao Wang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1101-1125
Open Access | Times Cited: 16

Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Shanqiang Qu, Rongyang Xu, Guozhong Yi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 14

Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
Jialong Zhu, Linlin Ji, Yitian Chen, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 33

Tumor organoid biobank-new platform for medical research
Xuexue Xie, Xinyu Li, Wei Song
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer
Xingfeng He, Yan Jiang, Long Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 21

Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10

Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P. Smabers, Emerens Wensink, Carla S. Veríssimo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7

Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
Danial Khorsandi, Jiawei Yang, Samuel Foster, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 21
Closed Access | Times Cited: 6

Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li, Weiqiang Gong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 6

Global Literature Analysis of Tumor Organoid and Tumor-on-Chip Research
Jun‐ya Shoji, Richard P. Davis, Christine L. Mummery, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 108-108
Open Access

Patient-Derived Organoid Models for NKT Cell-Based Cancer Immunotherapy
Pablo A. Palacios, Iván Flores, Lucas Cereceda, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 406-406
Open Access

Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access

Current Applications, Future Perspectives and Challenges of Organoid Technology in Oral Cancer Research
Yunyi Wang, Xiang Sun, LU Bing-xu, et al.
European Journal of Pharmacology (2025), pp. 177368-177368
Closed Access

Huachansu suppresses colorectal cancer via inhibiting PI3K/AKT and glycolysis signaling pathways: Systems biology and network pharmacology
Hongxuan YANG, Yixu Chen, Chun-Lan Dai, et al.
Journal of Ethnopharmacology (2025), pp. 119479-119479
Closed Access

The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
Chang Su, Kelly Landers, Catherine Bond, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 805-805
Open Access | Times Cited: 17

Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer
Tao Tan, Dmitri Mouradov, Margaret Lee, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101335-101335
Open Access | Times Cited: 16

A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
Dexter Kai Hao Thng, Lissa Hooi, Bei En Siew, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5

Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top